Evaluation of the safety and tolerability of rivaroxaban in dogs with presumed primary immune-mediated hemolytic anemia.
about
Evaluation of the safety and tolerability of rivaroxaban in dogs with presumed primary immune-mediated hemolytic anemia.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Evaluation of the safety and t ...... une-mediated hemolytic anemia.
@en
Evaluation of the safety and t ...... une-mediated hemolytic anemia.
@nl
type
label
Evaluation of the safety and t ...... une-mediated hemolytic anemia.
@en
Evaluation of the safety and t ...... une-mediated hemolytic anemia.
@nl
prefLabel
Evaluation of the safety and t ...... une-mediated hemolytic anemia.
@en
Evaluation of the safety and t ...... une-mediated hemolytic anemia.
@nl
P2093
P2860
P356
P1476
Evaluation of the safety and t ...... une-mediated hemolytic anemia.
@en
P2093
Domenico Bianco
George A White
Reid K Nakamura
P2860
P304
P356
10.1111/VEC.12480
P50
P577
2016-04-13T00:00:00Z